Procedure for Including Drugs on the Essential Drugs List: An Empirical Analysis of Decision-Making Factors
( Pp. 100-108)

More about authors
Ilona V. Tregub Dr. Sci. (Econ.), Professor
Financial University under the Government of the Russian Federation
Moscow, Russian Federation Anastasia R. Skripnik
Financial University under the Government of the Russian Federation
Moscow, Russian Federation
Abstract:
Goal: To identify the factors influencing decision-making by the Commission of the Ministry of Health of the Russian Federation regarding inclusion of new drugs in the Essential Drugs List. Methodology: A detailed analysis was conducted on the current procedure for forming drug lists established by Government Decree No. 871 of Russia. Regression methods were employed, including linear regression, logit-, and probit-models to determine dependencies between various factors and commission decisions about including a drug into the list. Results: Empirical analysis revealed that existing methodologies for health technology assessment contain shortcomings leading to distortions in decision-making processes. The performed regression analysis demonstrated no clear pattern between proposed characteristics of drugs and voting results of the Commission of the Ministry of Health of the Russian Federation. It is emphasized that further efforts are needed to improve the decision-making system and increase its transparency.
How to Cite:
Tregub, I.V., Skripnik, A.R. (2025). Procedure for including drugs on the essential drugs list: An empirical analysis of decision-making factors. Economic Problems and Legal Practice, 21(6), 100-108. DOI: 10.33693/2541-8025-2025-21-6-100-108. EDN: LTVSZI
Reference list:
Omelyanovsky V.V., Sura M.V., Avksentieva M.V., Kha­chatryan G.R. Rules for the formation of lists of medicinal products for medical use at the federal level: current status and development prospects. Medical Technologies. Evaluation and Selection. 2018. No. 3 (33). Pp. 9–17. (In Rus.). DOI:10.31556/2219-0678.2018.33.3.009-017. EDN: XYUWIP.
Omelyanovsky V.V., Maksimkina E.A., Ivakhnenko O.I. [et al.] Soimprovement of the system for forming lists of drugs medicinal products for human use: analysis amendments to Decree of the Government of the Russian Federation No. 871. Pharmacoeconomics. Modern Pharmacoeconomics and Pharmacoepidemiology. 2020. V. 13, No. 2. Pp. 113–123. (In Rus.). DOI: 10.17749/2070-4909/farmakoekonomika.2020.032. EDN: RBPZBS.
Kuksenok A.R. Analysis of deficiencies in current methods for assessing technical of health care in Russia and proposals for their implementation. Economy and Entrepreneurship. 2021. No. 6 (131). Pp. 1231–1236. (In Rus.). DOI: 10.34925/EIP.2021.131.6.240. EDN: OGICBI.
Bezpalova K.S., Mkhitaryan R.M., Dragulenko V.V. Main methods of econometric modeling: overview and comparison. Regional and Sectoral Economy. 2023. No. 5. Pp. 99–103. (In Rus.). DOI: 10.47576/2949-1916_2023_5_99. EDN: JUSPNO.
Chernykh M.S. Probit and logit models in econometrics / M.S. Chernykh, E. V. Kleimenova // Modern problems and prospects science, technology and education: Materials II National scientific and practical conference, Magnitogorsk, 10 December 2021 /Edited by I.A. Dolmatova. Magnitogorsk: Magnitogorsk State Technical University. G.I. Nosova, 2022. Pp. 438–441. EDN: IKSCTP.
Keywords:
health technology assessment, essential drugs list, regression analysis..